These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33221895)

  • 21. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Ishikawa T; Kimoto H; Mishima H; Yamagata K; Ogata S; Aizawa Y; Hayashi K; Morita H; Nakajima T; Nakano Y; Nagase S; Murakoshi N; Kowase S; Ohkubo K; Aiba T; Morimoto S; Ohno S; Kamakura S; Nogami A; Takagi M; Karakachoff M; Dina C; Schott JJ; Yoshiura KI; Horie M; Shimizu W; Nishimura K; Kusano K; Makita N
    Eur Heart J; 2021 Jul; 42(29):2854-2863. PubMed ID: 34219138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCN5A mutation in Brugada syndrome is associated with substrate severity detected by electrocardiographic imaging and high-density electroanatomic mapping.
    Pannone L; Monaco C; Sorgente A; Vergara P; Gauthey A; Calburean PA; Bisignani A; Paparella G; Ramak R; Overeinder I; Bala G; Almorad A; Ströker E; Pappaert G; Sieira J; Brugada P; Van Dooren S; de Ravel T; La Meir M; Chierchia GB; de Asmundis C
    Heart Rhythm; 2022 Jun; 19(6):945-951. PubMed ID: 35124229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copy number variations of SCN5A in Brugada syndrome.
    Sonoda K; Ohno S; Ozawa J; Hayano M; Hattori T; Kobori A; Yahata M; Aburadani I; Watanabe S; Matsumoto Y; Makiyama T; Horie M
    Heart Rhythm; 2018 Aug; 15(8):1179-1188. PubMed ID: 29574140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
    Wang QI; Ohno S; Ding WG; Fukuyama M; Miyamoto A; Itoh H; Makiyama T; Wu J; Bai J; Hasegawa K; Shinohara T; Takahashi N; Shimizu A; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 May; 25(5):522-530. PubMed ID: 24400717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters.
    Matsumura H; Nakano Y; Ochi H; Onohara Y; Sairaku A; Tokuyama T; Tomomori S; Motoda C; Amioka M; Hironobe N; Toshishige M; Takahashi S; Imai K; Sueda T; Chayama K; Kihara Y
    J Biomed Sci; 2017 Dec; 24(1):91. PubMed ID: 29202755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCN5A gene variants and arrhythmic risk in Brugada syndrome: An updated systematic review and meta-analysis.
    Doundoulakis I; Pannone L; Chiotis S; Della Rocca DG; Sorgente A; Tsioufis P; Del Monte A; Vetta G; Piperis C; Overeinder I; Bala G; Almorad A; Ströker E; Sieira J; La Meir M; Brugada P; Tsiachris D; Sarkozy A; Chierchia GB; de Asmundis C
    Heart Rhythm; 2024 Oct; 21(10):1987-1997. PubMed ID: 38614189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reentry in cardiac ventricular epicardial tissue due to SCN5A L812Q gene mutation: a computational study.
    Satish H; Reddy MR
    Biomed Phys Eng Express; 2022 Apr; 8(3):. PubMed ID: 35320795
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Makarawate P; Chaosuwannakit N; Vannaprasaht S; Sahasthas D; Koo SH; Lee EJD; Tassaneeyakul W; Barajas-Martinez H; Hu D; Sawanyawisuth K
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.
    Monasky MM; Micaglio E; Vicedomini G; Locati ET; Ciconte G; Giannelli L; Giordano F; Crisà S; Vecchi M; Borrelli V; Ghiroldi A; D'Imperio S; Di Resta C; Benedetti S; Ferrari M; Santinelli V; Anastasia L; Pappone C
    Europace; 2019 Oct; 21(10):1550-1558. PubMed ID: 31292628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
    Brugada J; Pappone C; Berruezo A; Vicedomini G; Manguso F; Ciconte G; Giannelli L; Santinelli V
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1373-81. PubMed ID: 26291334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
    Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
    Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel SCN10A variants associated with Brugada syndrome.
    Fukuyama M; Ohno S; Makiyama T; Horie M
    Europace; 2016 Jun; 18(6):905-11. PubMed ID: 25842276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
    Stokoe KS; Balasubramaniam R; Goddard CA; Colledge WH; Grace AA; Huang CL
    J Physiol; 2007 May; 581(Pt 1):255-75. PubMed ID: 17303635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
    Tanaka M; Nakamura K; Kusano KF; Morita H; Ohta-Ogo K; Miura D; Miura A; Nakagawa K; Tada T; Murakami M; Nishii N; Nagase S; Hata Y; Kohno K; Ouchida M; Shimizu K; Yutani C; Ohe T; Ito H
    Cardiovasc Pathol; 2011; 20(1):e37-42. PubMed ID: 20219395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinic and genetic polymorphism of Brugada syndrome in Russian patients, caused by mutation in SCN5A gene].
    Zakliaz'minskaia EV; Shestak AG; Revishvili ASh; Pronicheva IV; Podoliak DG; Nechaenko MA; Poliakov AV; Dzemeshkevich SL
    Khirurgiia (Mosk); 2013; (2):49-53. PubMed ID: 23503384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome.
    Chung FP; Raharjo SB; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang YT; Hung Y; Te A; Yamada S; Tasaka H; Wang CT; Chen SA
    Heart Rhythm; 2017 Apr; 14(4):508-517. PubMed ID: 28065832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.